It is reported that sponging of miR-151a-3p by lncRNA SBF2-AS1, which is more highly expressed in IDH-wildtype than IDH-mutant gliomas, is responsible for TMZ resistance in glioma cells (Zhang et al. 2019). The gene discussed is IDH2; the disease is central nervous system cancer.